Skip to main content
Log in

Dexamethasone increases plasma levels of albendazole

  • Original Investigations
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Summary

Therapy of neurocysticercosis with cysticidal drugs is frequently complicated by the exacerbation of symptoms that follows the inflammation triggered by the acute destruction of cysticerci. Treatment of such adverse reactions with dexamethasone is highly effective. However, it has been shown that dexamethasone lowers the plasma levels of praziquantel, thus reducing its cysticidal efficacy. We measured plasma levels of albendazole, another strong cysticidal drug, when dexamethasone was given simultaneously. We found that dexamethasone increased the plasma levels of albendazole by about 50% (P<0.002); hence, it seems that cysticercosis and the ensuing inflammation can be treated simultaneously with albendazole and dexamethasone without diminishing the efficacy of the cysticidal drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alarcon F, Perez Y, Banda H, Sotelo J (1988) Praziquantal and dexamethasone. Neurology 38:997–999

    Google Scholar 

  2. Alarcon F, Escalante L, Dueñas G, Montalvo M, Román M (1989) Neurocysticercosis: short course of treatment with albendazole. Arch Neurol 46:1231–1236

    Google Scholar 

  3. Earnest M, Rellor B, Filley C, Crek A (1987) Neurocysticercosis in the United States: 35 cases and a review. Rev Infect Dis 9:961–979

    Google Scholar 

  4. Hurtado M, Medina MT, Sotelo J, Jung H (1989) Sensitive high-performance liquid chromatographic assay for albendazole and its main metabolite albendazole sulphoxide in plasma and cerebrospinal fluid. J Chromatogr 494:403–407

    Google Scholar 

  5. Jung H, Hurtado M. Sánchez M, Medina MT, Sotelo J (1990) Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis. Clin Neuropharmacol (in press)

  6. Menlemans A, Giovanangeli MD, Mohler J, Vulpillat M, Hay JM, Saimot AG (1984) High performance liquid chromatography of albendazole and its sulfoxide metabolite in human organs and fluids during hydatidosis. J Liq Chromatogr 7:569–580

    Google Scholar 

  7. Moodley M, Moosa A (1989) Treatment of neurocysticercosis: is praziquantel the new hope? Lancet I:262

    Google Scholar 

  8. Sotelo J (1989) Praziquantel for neurocysticercosis. Lancet I:897

    Google Scholar 

  9. Sotelo J, Escobedo F, Rodríguez J, Torres B, Rubio F (1984) Therapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med 310:1001–1007

    Google Scholar 

  10. Sotelo J, Del Brutto OH, Penagos P, Escobedo F, Torres B, Rodríguez J, Rubio F (1990) Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol 237:69–72

    Google Scholar 

  11. Vazquez ML, Jung H, Sotelo J (1987) Plasma levels of praziquantel decrease when dexamethasone is given simultaneously. Neurology 37:1561–1562

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jung, H., Hurtado, M., Medina, M.T. et al. Dexamethasone increases plasma levels of albendazole. J Neurol 237, 279–280 (1990). https://doi.org/10.1007/BF00314741

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00314741

Key words

Navigation